| Year |
Citation |
Score |
| 2023 |
Sardo U, Perrier P, Cormier K, Sotin M, Personnaz J, Medjbeur T, Desquesnes A, Cannizzo L, Ruiz-Martinez M, Thevenin J, Billoré B, Jung G, Abboud E, Peyssonnaux C, Nemeth E, et al. The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling. Blood. PMID 38232308 DOI: 10.1182/blood.2023022724 |
0.67 |
|
| 2023 |
Banerjee S, Lu S, Jain A, Wang I, Tao H, Srinivasan S, Nemeth E, He P. Targeting PKC alleviates iron overload in diabetes and hemochromatosis. Biorxiv : the Preprint Server For Biology. PMID 38076948 DOI: 10.1101/2023.11.28.569107 |
0.412 |
|
| 2023 |
Barad A, Guillet R, Pressman EK, Katzman PJ, Ganz T, Nemeth E, O'Brien KO. Placental ferroportin protein abundance is associated with neonatal erythropoietic activity and iron status in newborns at high risk for iron deficiency and anemia. The American Journal of Clinical Nutrition. PMID 37890671 DOI: 10.1016/j.ajcnut.2023.10.022 |
0.707 |
|
| 2023 |
Srole DN, Jung G, Waring AJ, Nemeth E, Ganz T. Characterization of erythroferrone structural domains relevant to its iron-regulatory function. The Journal of Biological Chemistry. 105374. PMID 37866631 DOI: 10.1016/j.jbc.2023.105374 |
0.604 |
|
| 2023 |
Nair M, Choudhury SS, Rani A, Solomi C, Kakoty SD, Medhi R, Rao S, Mahanta P, Zahir F, Roy I, Chhabra S, Deka G, Minz B, Deka R, Opondo C, ... ... Nemeth E, et al. The complex relationship between iron status and anemia in pregnant and postpartum women in India: Analysis of two Indian study cohorts of uncomplicated pregnancies. American Journal of Hematology. PMID 37651649 DOI: 10.1002/ajh.27059 |
0.386 |
|
| 2023 |
Ganz T, Nemeth E. Hypoferremia of inflammation: Innate host defense against infections. Blood Cells, Molecules & Diseases. 102777. PMID 37391347 DOI: 10.1016/j.bcmd.2023.102777 |
0.629 |
|
| 2023 |
Sangkhae V, Fisher AL, Ganz T, Nemeth E. Iron Homeostasis During Pregnancy: Maternal, Placental, and Fetal Regulatory Mechanisms. Annual Review of Nutrition. PMID 37253681 DOI: 10.1146/annurev-nutr-061021-030404 |
0.628 |
|
| 2023 |
Delaney KM, Barad A, Castillo LF, Hasund CM, Guillet R, Pressman EK, Katzman PJ, Ganz T, Nemeth E, O'Brien KO. Placental Erythroferrone and Erythropoietin mRNA Expression is Not Associated with Maternal or Neonatal Iron Status in Adolescents Carrying Singletons and Adult Women Carrying Multiples. The Journal of Nutrition. PMID 37253412 DOI: 10.1016/j.tjnut.2023.05.023 |
0.623 |
|
| 2023 |
Yu Y, Woloshun RR, Lee JK, Ebea PO, Zhu S, Nemeth E, Garrick L, Garrick M, Collins JF. Fetal Factors Disrupt Placental and Maternal Iron Homeostasis in Murine β-Thalassemia. Blood. PMID 37146247 DOI: 10.1182/blood.2022018839 |
0.547 |
|
| 2023 |
Sardo U, Perrier P, Cormier K, Sotin M, Desquesnes A, Cannizzo L, Ruiz-Martinez M, Thevenin J, Billoré B, Jung G, Abboud E, Peyssonnaux C, Nemeth E, Ginzburg YZ, Ganz T, et al. The hepatokine FGL1 regulates hepcidin and iron metabolism during the recovery from hemorrhage-induced anemia in mice. Biorxiv : the Preprint Server For Biology. PMID 37066218 DOI: 10.1101/2023.04.06.535920 |
0.675 |
|
| 2023 |
Olivera JD, Zhang V, Nemeth E, Ganz T. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia. Blood Advances. PMID 36995275 DOI: 10.1182/bloodadvances.2022009307 |
0.638 |
|
| 2023 |
Azucenas CR, Ruwe TA, Bonamer JP, Qiao B, Ganz T, Jormakka M, Nemeth E, Mackenzie B. Comparative analysis of the functional properties of human and mouse ferroportin. American Journal of Physiology. Cell Physiology. PMID 36939203 DOI: 10.1152/ajpcell.00063.2023 |
0.763 |
|
| 2023 |
Ganz T, Nemeth E. Pathogenic Mechanisms in Thalassemia II: Iron Overload. Hematology/Oncology Clinics of North America. 37: 353-363. PMID 36907608 DOI: 10.1016/j.hoc.2022.12.006 |
0.689 |
|
| 2023 |
Stetka J, Usart M, Kubovcakova L, Rai S, Nageswara Rao T, Sutter J, Hao-Shen H, Dirnhofer S, Geier F, Bader MS, Passweg JR, Manolova V, Dürrenberger F, Ahmed N, Schroeder T, ... ... Nemeth E, et al. Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms. Blood. PMID 36758212 DOI: 10.1182/blood.2022017976 |
0.672 |
|
| 2023 |
Ganz T, Nemeth E, Rivella S, Goldberg P, Dibble AR, McCaleb ML, Guo S, Monia BP, Barrett TD. TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis. Advances in Therapy. PMID 36690839 DOI: 10.1007/s12325-022-02421-w |
0.73 |
|
| 2022 |
Zhang V, Ganz T, Nemeth E, Umar S, Kim A. Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension. Pulmonary Circulation. 12: e12151. PMID 36568690 DOI: 10.1002/pul2.12151 |
0.523 |
|
| 2022 |
Zhang V, Jenkitkasemwong S, Liu Q, Ganz T, Nemeth E, Knutson MD, Kim A. A mouse model characterizes the roles of ZIP8 in systemic iron recycling and lung inflammation and infection. Blood Advances. PMID 36260707 DOI: 10.1182/bloodadvances.2022007867 |
0.631 |
|
| 2022 |
González-Fernández D, Nemeth E, Pons EDC, Sinisterra OT, Rueda D, Starr L, Sangkhae V, Murillo E, Scott ME, Koski KG. Multiple Indicators of Undernutrition, Infection, and Inflammation in Lactating Women Are Associated with Maternal Iron Status and Infant Anthropometry in Panama: The MINDI Cohort. Nutrients. 14. PMID 36079755 DOI: 10.3390/nu14173497 |
0.371 |
|
| 2022 |
Sangkhae V, Yu V, Coffey R, O'Brien KO, Ganz T, Nemeth E. Erythroferrone contributes to iron mobilization for embryo erythropoiesis in iron-deficient mouse pregnancies. American Journal of Hematology. 97: 1348-1358. PMID 36071577 DOI: 10.1002/ajh.26680 |
0.72 |
|
| 2022 |
Nemeth E, Ganz T. Hepcidin and Iron in Health and Disease. Annual Review of Medicine. PMID 35905974 DOI: 10.1146/annurev-med-043021-032816 |
0.733 |
|
| 2022 |
Wang Y, Wang M, Liu Y, Tao H, Banerjee S, Srinivasan S, Nemeth E, Czaja MJ, He P. Integrated regulation of stress responses, autophagy and survival by altered intracellular iron stores. Redox Biology. 55: 102407. PMID 35853304 DOI: 10.1016/j.redox.2022.102407 |
0.568 |
|
| 2022 |
Sangkhae V, Nemeth E. Quantitating Iron Transport across the Mouse Placenta In Vivo using Nonradioactive Iron Isotopes. Journal of Visualized Experiments : Jove. PMID 35635455 DOI: 10.3791/63378 |
0.583 |
|
| 2022 |
Andersen AB, Bejder J, Bonne TC, Sørensen H, Sørensen H, Jung G, Ganz T, Nemeth E, Secher NH, Johansson PI, Nordsborg NB. Hepcidin and Erythroferrone Complement the Athlete Biological Passport in the Detection of Autologous Blood Transfusion. Medicine and Science in Sports and Exercise. PMID 35482790 DOI: 10.1249/MSS.0000000000002950 |
0.392 |
|
| 2022 |
Luo G, Zhang J, Wang H, Sun Y, Cheng B, Xu Z, Zhang Y, Li H, Lu W, Nemeth E, Ganz T, Fang X. Human defensin-inspired discovery of peptidomimetic antibiotics. Proceedings of the National Academy of Sciences of the United States of America. 119: e2117283119. PMID 35238683 DOI: 10.1073/pnas.2117283119 |
0.356 |
|
| 2022 |
Zhou A, Kong T, Fowles JS, Jung CL, Allen MJ, Fisher DAC, Fulbright M, Nemeth E, Ganz T, Oh ST. Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib. British Journal of Haematology. PMID 35128632 DOI: 10.1111/bjh.18044 |
0.397 |
|
| 2021 |
Hanudel MR, Czaya B, Wong S, Rappaport M, Namjoshi S, Chua K, Jung G, Gabayan V, Qiao B, Nemeth E, Ganz T. Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin. Kidney International. PMID 34838540 DOI: 10.1016/j.kint.2021.10.036 |
0.729 |
|
| 2021 |
Coffey R, Jung CG, Olivera JD, Karin G, Pereira RC, Nemeth E, Ganz T. Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice. Blood. PMID 34614145 DOI: 10.1182/blood.2021014054 |
0.703 |
|
| 2021 |
Fisher AL, Srole DN, Palaskas NJ, Meriwether D, Reddy ST, Ganz T, Nemeth E. Iron loading induces cholesterol synthesis and sensitizes endothelial cells to TNFα-mediated apoptosis. The Journal of Biological Chemistry. 101156. PMID 34480898 DOI: 10.1016/j.jbc.2021.101156 |
0.665 |
|
| 2021 |
Drakesmith H, Pasricha SR, Cabantchik I, Hershko C, Weiss G, Girelli D, Stoffel N, Muckenthaler MU, Nemeth E, Camaschella C, Klenerman P, Zimmermann MB. Vaccine efficacy and iron deficiency: an intertwined pair? The Lancet. Haematology. 8: e666-e669. PMID 34450104 DOI: 10.1016/S2352-3026(21)00201-5 |
0.311 |
|
| 2021 |
Delaney KM, Guillet R, Pressman EK, Ganz T, Nemeth E, O'Brien KO. Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples. The Journal of Nutrition. PMID 34236433 DOI: 10.1093/jn/nxab156 |
0.708 |
|
| 2021 |
Nemeth E, Ganz T. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis. International Journal of Molecular Sciences. 22. PMID 34204327 DOI: 10.3390/ijms22126493 |
0.739 |
|
| 2021 |
Fisher AL, Sangkhae V, Balušíková K, Palaskas NJ, Ganz T, Nemeth E. Iron-dependent apoptosis causes embryotoxicity in inflamed and obese pregnancy. Nature Communications. 12: 4026. PMID 34188052 DOI: 10.1038/s41467-021-24333-z |
0.66 |
|
| 2021 |
Breenfeldt Andersen A, Bonne TC, Bejder J, Jung G, Ganz T, Nemeth E, Olsen NV, Rodriguez Huertas J, Nordsborg NB. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. PMID 34160288 DOI: 10.1152/ajpregu.00070.2021 |
0.609 |
|
| 2021 |
Tussing-Humphreys L, LaBomascus B, O'Brien K, Nemeth E, Sangkhae V, Steffen AD, Castellanos K, DeMartelly V, Ruchob R, Welke L, Hemphill NO, Pezley L, McLeod A, Hirsch B, Elam G, et al. Prepregnancy Obesity Does Not Impact Placental Iron Trafficking. The Journal of Nutrition. PMID 34132349 DOI: 10.1093/jn/nxab191 |
0.47 |
|
| 2021 |
Castro-Mollo M, Gera S, Ruiz Martinez M, Feola M, Gumerova A, Planoutene M, Clementelli C, Sangkhae V, Casu C, Kim SM, Ostland V, Han H, Nemeth E, Fleming R, Rivella S, et al. The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry. Elife. 10. PMID 34002695 DOI: 10.7554/eLife.68217 |
0.423 |
|
| 2021 |
Delaney KM, Guillet R, Pressman EK, Ganz T, Nemeth E, O'Brien KO. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia. The Journal of Nutrition. PMID 33982118 DOI: 10.1093/jn/nxab093 |
0.634 |
|
| 2021 |
Goncalves Monteiro D, van Dijk JWA, Aliyanto R, Fung E, Nemeth E, Ganz T, Rosengren J, Clark RJ. Pursuing Orally Bioavailable Hepcidin Analogues via Cyclic -Methylated Mini-Hepcidins. Biomedicines. 9. PMID 33567510 DOI: 10.3390/biomedicines9020164 |
0.67 |
|
| 2021 |
Richards T, Breymann C, Brookes MJ, Lindgren S, Macdougall IC, McMahon LP, Munro MG, Nemeth E, Rosano GMC, Schiefke I, Weiss G. Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice. Annals of Medicine. 53: 274-285. PMID 33426933 DOI: 10.1080/07853890.2020.1867323 |
0.618 |
|
| 2020 |
Deshpande CN, Azucenas CR, Qiao B, Nomura N, Xin V, Font J, Iwata S, Ganz T, Nemeth E, Mackenzie B, Jormakka M. Isolation and thermal stabilization of mouse ferroportin. Febs Open Bio. PMID 33190422 DOI: 10.1002/2211-5463.13039 |
0.735 |
|
| 2020 |
Zhang V, Nemeth E, Kim A. Lung Iron Overload Does Not Exacerbate the Fibrotic Response to Bleomycin in a Mouse Model of Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 63: 713-716. PMID 33124901 DOI: 10.1165/rcmb.2020-0192LE |
0.339 |
|
| 2020 |
Jerzak KJ, Lohmann AE, Ennis M, Nemeth E, Ganz T, Goodwin PJ. Prognostic associations of plasma hepcidin in women with early breast cancer. Breast Cancer Research and Treatment. PMID 32960376 DOI: 10.1007/S10549-020-05903-Z |
0.653 |
|
| 2020 |
Gutschow P, Han H, Olbina G, Westerman K, Nemeth E, Ganz T, Copeland K, Westerman M, Ostland V. Clinical Immunoassay for Human Hepcidin Predicts Iron Deficiency in First-Time Blood Donors. The Journal of Applied Laboratory Medicine. PMID 32674118 DOI: 10.1093/jalm/jfaa038 |
0.709 |
|
| 2020 |
Zhang V, Ganz T, Nemeth E, Kim A. Iron overload causes a mild and transient increase in acute lung injury. Physiological Reports. 8: e14470. PMID 32596989 DOI: 10.14814/Phy2.14470 |
0.668 |
|
| 2020 |
Sangkhae V, Fisher AL, Chua KJ, Ruchala P, Ganz T, Nemeth E. Maternal Hepcidin Determines Embryo Iron Homeostasis. Blood. PMID 32584957 DOI: 10.1182/Blood.2020005745 |
0.7 |
|
| 2020 |
Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Author Correction: Identification of erythroferrone as an erythroid regulator of iron metabolism. Nature Genetics. PMID 32107478 DOI: 10.1038/S41588-019-0548-Y |
0.641 |
|
| 2020 |
Mangaonkar AA, Thawer F, Son J, Ajebo G, Xu H, Barrett NJ, Wells LG, Bowman L, Clair B, Patel N, Bora P, Jung G, Nemeth E, Kutlar A. Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease. British Journal of Haematology. PMID 32030737 DOI: 10.1111/Bjh.16498 |
0.452 |
|
| 2020 |
Fisher AL, Sangkhae V, Presicce P, Chougnet CA, Jobe AH, Kallapur SG, Tabbah SM, Buhimschi CS, Buhimschi IA, Ganz T, Nemeth E. Fetal and amniotic fluid iron homeostasis in healthy and complicated murine, macaque, and human pregnancy. Jci Insight. PMID 31990688 DOI: 10.1172/Jci.Insight.135321 |
0.678 |
|
| 2020 |
Ruwe TA, Qiao B, Bonamer JP, Azucenas CR, Ganz T, Nemeth E, Mackenzie B. Hepcidin inhibits ferroportin in the
Xenopus
oocyte expression system via a calcium‐dependent mechanism that does not involve endocytosis The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04800 |
0.606 |
|
| 2019 |
Sangkhae V, Fisher AL, Wong S, Koenig MD, Tussing-Humphreys L, Chu A, Lelić M, Ganz T, Nemeth E. Effects of maternal iron status on placental and fetal iron homeostasis. The Journal of Clinical Investigation. PMID 31661462 DOI: 10.1172/Jci127341 |
0.752 |
|
| 2019 |
Bondu S, Alary AS, Lefèvre C, Houy A, Jung G, Lefebvre T, Rombaut D, Boussaid I, Bousta A, Guillonneau F, Perrier P, Alsafadi S, Wassef M, Margueron R, Rousseau A, ... ... Nemeth E, et al. A variant erythroferrone disrupts iron homeostasis in -mutated myelodysplastic syndrome. Science Translational Medicine. 11. PMID 31292266 DOI: 10.1126/Scitranslmed.Aav5467 |
0.668 |
|
| 2019 |
Sangkhae V, Nemeth E. To induce or not to induce: the fight over hepcidin regulation. Haematologica. 104: 1093-1095. PMID 31152085 DOI: 10.3324/Haematol.2019.216960 |
0.672 |
|
| 2019 |
Hall R, Peeling P, Nemeth E, Bergland D, McCluskey WTP, Stellingwerff T. Single versus Split Dose of Iron Optimizes Hemoglobin Mass Gains at 2106 m Altitude. Medicine and Science in Sports and Exercise. 51: 751-759. PMID 30882751 DOI: 10.1249/Mss.0000000000001847 |
0.504 |
|
| 2019 |
Zhang V, Nemeth E, Kim A. Iron in Lung Pathology. Pharmaceuticals (Basel, Switzerland). 12. PMID 30781366 DOI: 10.3390/Ph12010030 |
0.578 |
|
| 2019 |
Delaney KM, Guillet R, Fleming RE, Ru Y, Pressman EK, Vermeylen F, Nemeth E, O'Brien KO. Umbilical Cord Serum Ferritin Concentration is Inversely Associated with Umbilical Cord Hemoglobin in Neonates Born to Adolescents Carrying Singletons and Women Carrying Multiples. The Journal of Nutrition. PMID 30770543 DOI: 10.1093/Jn/Nxy286 |
0.523 |
|
| 2019 |
Micewicz ED, Iwamoto KS, Ratikan JA, Nguyen C, Xie MW, Cheng G, Boxx GM, Deriu E, Damoiseaux RD, Whitelegge JP, Ruchala PP, Avetisyan R, Jung ME, Lawson G, Nemeth E, et al. The Aftermath of Surviving Acute Radiation Hematopoietic Syndrome and its Mitigation. Radiation Research. PMID 30730284 DOI: 10.1667/Rr15231.1 |
0.434 |
|
| 2019 |
Chen Q, Yang Y, Hou J, Shu Q, Yin Y, Fu W, Han F, Hou T, Zeng C, Nemeth E, Linzmeier R, Ganz T, Fang X. Increased gene copy number of worsens sepsis by inducing endothelial pyroptosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 30718392 DOI: 10.1073/Pnas.1812947116 |
0.462 |
|
| 2019 |
Gutschow P, Han H, Olbina G, Westerman K, Westerman E, Ruiz Martinez M, Ginzburg Y, Nemeth E, Ganz T, Ostland V. A Novel Sandwich ELISA to Quantify Erythroferrone in Mouse Serum Blood. 134: 2237-2237. DOI: 10.1182/Blood-2019-130947 |
0.548 |
|
| 2019 |
Thompson AA, Ganz T, Forsyth MT, Nemeth E, Badawy SM. Does Gene Therapy in Beta Thalassemia Normalize Novel Markers of Ineffective Erythropoiesis and Iron Homeostasis? Blood. 134: 816-816. DOI: 10.1182/Blood-2019-129658 |
0.625 |
|
| 2018 |
Hall R, Peeling P, Nemeth E, Bergland D, McCluskey WTP, Stellingwerff T. Single versus Split Dose of Iron Optimizes Haemoglobin Mass Gains at 2106 m Altitude. Medicine and Science in Sports and Exercise. PMID 30439788 DOI: 10.1249/MSS.0000000000001847 |
0.399 |
|
| 2018 |
Guo Y, Zhang N, Zhang D, Ren Q, Ganz T, Liu S, Nemeth E. Iron homeostasis in pregnancy and spontaneous abortion. American Journal of Hematology. PMID 30394565 DOI: 10.1002/Ajh.25341 |
0.706 |
|
| 2018 |
Schwartz AJ, Das NK, Ramakrishnan SK, Jain C, Jurkovic M, Wu J, Nemeth E, Lakhal-Littleton S, Colacino JA, Shah YM. Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload. The Journal of Clinical Investigation. PMID 30352047 DOI: 10.1172/Jci122359 |
0.673 |
|
| 2018 |
Gagliano-Jucá T, Pencina KM, Ganz T, Travison TG, Kantoff PW, Nguyen PL, Taplin ME, Kibel AS, Li Z, Huang G, Edwards RR, Nemeth E, Basaria S. Mechanisms Responsible for Reduced Erythropoiesis during Androgen Deprivation Therapy in Men with Prostate Cancer. American Journal of Physiology. Endocrinology and Metabolism. PMID 30325657 DOI: 10.1152/Ajpendo.00272.2018 |
0.565 |
|
| 2018 |
Coffey R, Sardo U, Kautz L, Gabayan V, Nemeth E, Ganz T. Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice. Physiological Reports. 6: e13890. PMID 30315639 DOI: 10.14814/Phy2.13890 |
0.514 |
|
| 2018 |
Deshpande CN, Ruwe TA, Shawki A, Xin V, Vieth KR, Valore EV, Qiao B, Ganz T, Nemeth E, Mackenzie B, Jormakka M. Calcium is an essential cofactor for metal efflux by the ferroportin transporter family. Nature Communications. 9: 3075. PMID 30082682 DOI: 10.1038/S41467-018-05446-4 |
0.772 |
|
| 2018 |
Hanudel MR, Eisenga MF, Rappaport M, Chua K, Qiao B, Jung G, Gabayan V, Gales B, Ramos G, de Jong MA, van Zanden JJ, de Borst MH, Bakker SJL, Nemeth E, Salusky IB, et al. Effects of erythropoietin on fibroblast growth factor 23 in mice and humans. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 30007314 DOI: 10.1093/Ndt/Gfy189 |
0.434 |
|
| 2018 |
Sangkhae V, Nemeth E. Placental iron transport: the mechanism and regulatory circuits. Free Radical Biology & Medicine. PMID 29981833 DOI: 10.1016/J.Freeradbiomed.2018.07.001 |
0.593 |
|
| 2018 |
Stefanova D, Raychev A, Deville J, Humphries R, Campeau S, Ruchala P, Nemeth E, Ganz T, Bulut Y. Hepcidin protects against lethal sepsis in mice inoculated with isolates from septic patients. Infection and Immunity. PMID 29735522 DOI: 10.1128/Iai.00253-18 |
0.722 |
|
| 2018 |
Meznarich JA, Draper L, Christensen RD, Yaish HM, Luem ND, Pysher TJ, Jung G, Nemeth E, Ganz T, Ward DM. Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations. Blood Cells, Molecules & Diseases. PMID 29599085 DOI: 10.1016/J.Bcmd.2018.03.002 |
0.636 |
|
| 2018 |
Adams P, Altes A, Brissot P, Butzeck B, Cabantchik I, Cançado R, Distante S, Evans P, Evans R, Ganz T, Girelli D, Hultcrantz R, McLaren G, Marris B, Milman N, ... Nemeth E, et al. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype. Hepatology International. PMID 29589198 DOI: 10.1007/S12072-018-9855-0 |
0.429 |
|
| 2018 |
Garvican-Lewis LA, Vuong VL, Govus AD, Peeling P, Jung G, Nemeth E, Hughes D, Lovell G, Eichner D, Gore CJ. Intravenous Iron Does Not Augment the Haemoglobin Mass Response to Simulated Hypoxia. Medicine and Science in Sports and Exercise. PMID 29538179 DOI: 10.1249/Mss.0000000000001608 |
0.63 |
|
| 2018 |
Casu C, Nemeth E, Rivella S. Hepcidin agonists as therapeutic tools. Blood. PMID 29523504 DOI: 10.1182/Blood-2017-11-737411 |
0.615 |
|
| 2018 |
Hanudel MR, Rappaport M, Chua K, Gabayan V, Qiao B, Jung G, Salusky IB, Ganz T, Nemeth E. Levels of the erythropoietin-responsive hormone erythroferrone in mice and humans with chronic kidney disease. Haematologica. PMID 29419424 DOI: 10.3324/Haematol.2017.181743 |
0.698 |
|
| 2017 |
Aschemeyer S, Qiao B, Stefanova D, Valore EV, Sek AC, Ruwe TA, Vieth KR, Jung G, Casu C, Rivella S, Jormakka M, Mackenzie B, Ganz T, Nemeth E. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood. PMID 29237594 DOI: 10.1182/Blood-2017-05-786590 |
0.771 |
|
| 2017 |
Fisher AL, Nemeth E. Iron homeostasis during pregnancy. The American Journal of Clinical Nutrition. PMID 29070542 DOI: 10.3945/Ajcn.117.155812 |
0.611 |
|
| 2017 |
Clinkenbeard EL, Hanudel MR, Stayrook KR, Appaiah HN, Farrow EG, Cass TA, Summers LJ, Ip CS, Hum JM, Thomas JC, Ivan M, Richine BM, Chan RJ, Clemens TL, Schipani E, ... ... Nemeth E, et al. Erythropoietin stimulates murine and human Fibroblast growth factor-23, revealing novel roles for bone and bone marrow. Haematologica. PMID 28818868 DOI: 10.3324/Haematol.2017.167882 |
0.413 |
|
| 2017 |
McLachlan S, Page KE, Lee SM, Loguinov A, Valore E, Hui ST, Jung G, Zhou J, Lusis AJ, Fuqua B, Ganz T, Nemeth E, Vulpe CD. Hamp1 mRNA and plasma hepcidin levels are influenced by sex and strain but don't predict tissue iron levels in inbred mice. American Journal of Physiology. Gastrointestinal and Liver Physiology. ajpgi.00307.2016. PMID 28798083 DOI: 10.1152/Ajpgi.00307.2016 |
0.691 |
|
| 2017 |
Ganz T, Jung G, Naeim A, Ginzburg Y, Pakbaz Z, Walter PB, Kautz L, Nemeth E. Immunoassay for human serum erythroferrone. Blood. PMID 28739636 DOI: 10.1182/Blood-2017-04-777987 |
0.66 |
|
| 2017 |
Stefanova D, Raychev A, Arezes J, Ruchala P, Gabayan V, Skurnik M, Dillon BJ, Horwitz MA, Ganz T, Bulut Y, Nemeth E. Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron. Blood. PMID 28465342 DOI: 10.1182/Blood-2017-03-772715 |
0.722 |
|
| 2017 |
Khorramian E, Fung E, Chua K, Gabayan V, Ganz T, Nemeth E, Kim A. In a Mouse Model of Sepsis, Hepcidin Ablation Ameliorates Anemia More Effectively Than Iron and Erythropoietin Treatment. Shock (Augusta, Ga.). PMID 28452907 DOI: 10.1097/Shk.0000000000000886 |
0.601 |
|
| 2017 |
Michels KR, Zhang Z, Bettina AM, Cagnina RE, Stefanova D, Burdick MD, Vaulont S, Nemeth E, Ganz T, Mehrad B. Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia. Jci Insight. 2: e92002. PMID 28352667 DOI: 10.1172/Jci.Insight.92002 |
0.704 |
|
| 2017 |
Aschemeyer S, Gabayan V, Ganz T, Nemeth E, Kautz L. Erythroferrone and matriptase-2 independently regulate hepcidin expression. American Journal of Hematology. PMID 28187515 DOI: 10.1002/Ajh.24672 |
0.466 |
|
| 2017 |
Sangkhae V, Nemeth E. Regulation of the Iron Homeostatic Hormone Hepcidin. Advances in Nutrition (Bethesda, Md.). 8: 126-136. PMID 28096133 DOI: 10.3945/An.116.013961 |
0.693 |
|
| 2016 |
Hanudel MR, Rappaport M, Gabayan V, Jung G, Salusky IB, Nemeth E, Ganz T, Zaritsky J. Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model. Haematologica. PMID 27884972 DOI: 10.3324/Haematol.2016.150433 |
0.503 |
|
| 2016 |
Welke L, Koenig MD, Thomson JL, Nemeth E, White-Traut R, McFarlin BL, Giurgescu C, Engeland C, Kominiarek MA, Tussing-Humphreys L. Iron Metabolism in African American Women in the Second and Third Trimesters of High-Risk Pregnancies. Journal of Obstetric, Gynecologic, and Neonatal Nursing : Jognn. PMID 27836659 DOI: 10.1016/J.Jogn.2016.06.013 |
0.426 |
|
| 2016 |
Hanudel MR, Chua K, Rappaport M, Gabayan V, Valore E, Goltzman D, Ganz T, Nemeth E, Salusky IB. Effects of Dietary Iron Intake and Chronic Kidney Disease on Fibroblast Growth Factor 23 Metabolism in Wild Type and Hepcidin Knockout Mice. American Journal of Physiology. Renal Physiology. ajprenal.00281.2016. PMID 27733366 DOI: 10.1152/Ajprenal.00281.2016 |
0.716 |
|
| 2016 |
Ganz T, Nemeth E. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease. Seminars in Nephrology. 36: 87-93. PMID 27236128 DOI: 10.1016/J.Semnephrol.2016.02.001 |
0.757 |
|
| 2016 |
Casu C, Oikonomidou PR, Chen H, Nandi V, Ginzburg Y, Prasad P, Fleming RE, Shah YM, Valore EV, Nemeth E, Ganz T, MacDonald B, Rivella S. Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera. Blood. PMID 27154187 DOI: 10.1182/Blood-2015-10-676742 |
0.684 |
|
| 2016 |
Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood. PMID 27044621 DOI: 10.1182/Blood-2015-12-639112 |
0.656 |
|
| 2016 |
Kim A, Fung E, Parikh SG, Gabayan V, Nemeth E, Ganz T. Isocitrate treatment of acute anemia of inflammation in a mouse model. Blood Cells, Molecules & Diseases. 56: 31-6. PMID 26603720 DOI: 10.1016/J.Bcmd.2015.09.007 |
0.588 |
|
| 2016 |
Kautz L, Aschemeyer S, Gabayan V, Ganz T, Nemeth E. Erythroferrone Regulates Hepcidin Expression Independently of Matriptase 2 Blood. 128: 3616-3616. DOI: 10.1182/Blood.V128.22.3616.3616 |
0.701 |
|
| 2016 |
Stefanova D, Arezes J, Michels K, Dillon B, Horwitz M, Mehrad B, Bulut Y, Ganz T, Nemeth E. Hepcidin Protects Against Extracellular Infections By Eliminating Non-Transferrin-Bound Iron Blood. 128: 260-260. DOI: 10.1182/Blood.V128.22.260.260 |
0.721 |
|
| 2015 |
Drakesmith H, Nemeth E, Ganz T. Ironing out Ferroportin. Cell Metabolism. 22: 777-87. PMID 26437604 DOI: 10.1016/J.Cmet.2015.09.006 |
0.755 |
|
| 2015 |
Michels K, Nemeth E, Ganz T, Mehrad B. Hepcidin and Host Defense against Infectious Diseases. Plos Pathogens. 11: e1004998. PMID 26291319 DOI: 10.1371/Journal.Ppat.1004998 |
0.731 |
|
| 2015 |
Kautz L, Jung G, Du X, Gabayan V, Chapman J, Nasoff M, Nemeth E, Ganz T. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia. Blood. PMID 26276665 DOI: 10.1182/Blood-2015-07-658419 |
0.695 |
|
| 2015 |
Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nature Reviews. Immunology. 15: 500-10. PMID 26160612 DOI: 10.1038/Nri3863 |
0.74 |
|
| 2015 |
Arezes J, Nemeth E. Hepcidin and iron disorders: new biology and clinical approaches. International Journal of Laboratory Hematology. 37: 92-8. PMID 25976966 DOI: 10.1111/ijlh.12358 |
0.597 |
|
| 2015 |
Chua K, Fung E, Micewicz ED, Ganz T, Nemeth E, Ruchala P. Small cyclic agonists of iron regulatory hormone hepcidin. Bioorganic & Medicinal Chemistry Letters. PMID 25813158 DOI: 10.1016/J.Bmcl.2015.03.012 |
0.579 |
|
| 2015 |
Keel SB, Doty R, Liu L, Nemeth E, Cherian S, Ganz T, Abkowitz JL. Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver. Experimental Hematology. 43: 469-478.e6. PMID 25782630 DOI: 10.1016/J.Exphem.2015.03.001 |
0.62 |
|
| 2015 |
Kim A, Nemeth E. New insights into iron regulation and erythropoiesis. Current Opinion in Hematology. 22: 199-205. PMID 25710710 DOI: 10.1097/Moh.0000000000000132 |
0.649 |
|
| 2015 |
Fung E, Chua K, Ganz T, Nemeth E, Ruchala P. Thiol-derivatized minihepcidins retain biological activity. Bioorganic & Medicinal Chemistry Letters. 25: 763-6. PMID 25599838 DOI: 10.1016/J.Bmcl.2014.12.094 |
0.502 |
|
| 2015 |
Arezes J, Jung G, Gabayan V, Valore E, Ruchala P, Gulig PA, Ganz T, Nemeth E, Bulut Y. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host & Microbe. 17: 47-57. PMID 25590758 DOI: 10.1016/J.Chom.2014.12.001 |
0.694 |
|
| 2015 |
Gutschow P, Schmidt PJ, Han H, Ostland V, Bartnikas TB, Pettiglio MA, Herrera C, Butler JS, Nemeth E, Ganz T, Fleming MD, Westerman M. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis. Haematologica. 100: 167-77. PMID 25425686 DOI: 10.3324/Haematol.2014.116723 |
0.755 |
|
| 2015 |
Shawki A, Ruwe TA, Mitchell C, Prakash S, Nemeth E, Ganz T, Mackenzie B. Ferroportin-mediated cellular iron efflux requires extracellular calcium The Faseb Journal. 29. DOI: 10.1096/Fasebj.29.1_Supplement.566.15 |
0.799 |
|
| 2014 |
Kautz L, Jung G, Nemeth E, Ganz T. Erythroferrone contributes to recovery from anemia of inflammation. Blood. 124: 2569-74. PMID 25193872 DOI: 10.1182/Blood-2014-06-584607 |
0.728 |
|
| 2014 |
Zhang S, Chen Y, Guo W, Yuan L, Zhang D, Xu Y, Nemeth E, Ganz T, Liu S. Disordered hepcidin-ferroportin signaling promotes breast cancer growth. Cellular Signalling. 26: 2539-50. PMID 25093806 DOI: 10.1016/J.Cellsig.2014.07.029 |
0.611 |
|
| 2014 |
Koenig MD, Tussing-Humphreys L, Day J, Cadwell B, Nemeth E. Hepcidin and iron homeostasis during pregnancy. Nutrients. 6: 3062-83. PMID 25093277 DOI: 10.3390/Nu6083062 |
0.548 |
|
| 2014 |
Nemeth E, Ganz T. Anemia of inflammation. Hematology/Oncology Clinics of North America. 28: 671-81, vi. PMID 25064707 DOI: 10.1016/J.Hoc.2014.04.005 |
0.706 |
|
| 2014 |
Domenico ID, Nemeth E, Nelson JM, Phillips JD, Ajioka RS, Kay MS, Kushner JP, Ganz T, Ward DM, Kaplan J. Retraction notice to: The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metabolism. 19: 1067-1067. PMID 25025111 DOI: 10.1016/J.Cmet.2014.05.010 |
0.427 |
|
| 2014 |
Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nature Genetics. 46: 678-84. PMID 24880340 DOI: 10.1038/Ng.2996 |
0.747 |
|
| 2014 |
Kautz L, Nemeth E. Molecular liaisons between erythropoiesis and iron metabolism. Blood. 124: 479-82. PMID 24876565 DOI: 10.1182/Blood-2014-05-516252 |
0.675 |
|
| 2014 |
Pusatcioglu CK, Nemeth E, Fantuzzi G, Llor X, Freels S, Tussing-Humphreys L, Cabay RJ, Linzmeier R, Ng D, Clark J, Braunschweig C. Systemic and tumor level iron regulation in men with colorectal cancer: a case control study. Nutrition & Metabolism. 11: 21. PMID 24872837 DOI: 10.1186/1743-7075-11-21 |
0.661 |
|
| 2014 |
Kim A, Rivera S, Shprung D, Limbrick D, Gabayan V, Nemeth E, Ganz T. Mouse models of anemia of cancer. Plos One. 9: e93283. PMID 24681760 DOI: 10.1371/Journal.Pone.0093283 |
0.517 |
|
| 2014 |
Ruchala P, Nemeth E. The pathophysiology and pharmacology of hepcidin. Trends in Pharmacological Sciences. 35: 155-61. PMID 24552640 DOI: 10.1016/J.Tips.2014.01.004 |
0.651 |
|
| 2014 |
Rodriguez R, Jung CL, Gabayan V, Deng JC, Ganz T, Nemeth E, Bulut Y. Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infection and Immunity. 82: 745-52. PMID 24478088 DOI: 10.1128/Iai.00983-13 |
0.55 |
|
| 2014 |
Kim A, Fung E, Parikh SG, Valore EV, Gabayan V, Nemeth E, Ganz T. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood. 123: 1129-36. PMID 24357728 DOI: 10.1182/Blood-2013-08-521419 |
0.712 |
|
| 2014 |
Mitchell CJ, Shawki A, Ganz T, Nemeth E, Mackenzie B. Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc. American Journal of Physiology. Cell Physiology. 306: C450-9. PMID 24304836 DOI: 10.1152/Ajpcell.00348.2013 |
0.79 |
|
| 2014 |
Nemeth E, Ganz T, Kautz L. Erythron to the Liver: Send Iron Blood. 124: SCI-37-SCI-37. DOI: 10.1182/Blood.V124.21.Sci-37.Sci-37 |
0.744 |
|
| 2014 |
Casu C, Oikonomidau R, Shah Y, Nemeth E, Ganz T, MacDonald B, Rivella S. Concurrent Treatment with Minhepcidin and Deferiprone Improves Anemia and Enhances Reduction of Spleen Iron in a Mouse Model of Non-Transfusion Dependent Thalassemia Blood. 124: 748-748. DOI: 10.1182/Blood.V124.21.748.748 |
0.737 |
|
| 2014 |
Casu C, Oikonomidau R, Nemeth E, Ganz T, MacDonald B, Rivella S. Use of Minihepcidins As a “Medical Phlebotomy” in the Treatment of Polycythemia Vera Blood. 124: 3231-3231. DOI: 10.1182/Blood.V124.21.3231.3231 |
0.677 |
|
| 2014 |
Kautz L, Jung G, Nemeth E, Ganz T. Role of Erythroferrone in the Pathophysiology of Common Anemias Blood. 124: 213-213. DOI: 10.1182/Blood.V124.21.213.213 |
0.661 |
|
| 2014 |
Parikh S, Fung E, Nemeth E, Ganz T, Kim A. Isocitrate Reverses Anemia of Inflammation in a Mouse Model Treated with Heat-Killed Brucella Abortus Blood. 124: 1349-1349. DOI: 10.1182/Blood.V124.21.1349.1349 |
0.59 |
|
| 2013 |
Kautz L, Gabayan V, Wang X, Wu J, Onwuzurike J, Jung G, Qiao B, Lusis AJ, Ganz T, Nemeth E. Testing the iron hypothesis in a mouse model of atherosclerosis. Cell Reports. 5: 1436-42. PMID 24316081 DOI: 10.1016/J.Celrep.2013.11.009 |
0.747 |
|
| 2013 |
Fung E, Nemeth E. Manipulation of the hepcidin pathway for therapeutic purposes. Haematologica. 98: 1667-76. PMID 24186312 DOI: 10.3324/Haematol.2013.084624 |
0.656 |
|
| 2013 |
Nemeth E. Anti-hepcidin therapy for iron-restricted anemias. Blood. 122: 2929-31. PMID 24159166 DOI: 10.1182/Blood-2013-08-522466 |
0.524 |
|
| 2013 |
Clark RJ, Preza GC, Tan CC, van Dijk JW, Fung E, Nemeth E, Ganz T, Craik DJ. Design, synthesis, and characterization of cyclic analogues of the iron regulatory peptide hormone hepcidin. Biopolymers. 100: 519-26. PMID 23897622 DOI: 10.1002/Bip.22350 |
0.631 |
|
| 2013 |
Nemeth E. Hepcidin and β-thalassemia major. Blood. 122: 3-4. PMID 23828883 DOI: 10.1182/Blood-2013-05-502617 |
0.525 |
|
| 2013 |
Preza GC, Pinon R, Ganz T, Nemeth E. Cellular catabolism of the iron-regulatory peptide hormone hepcidin. Plos One. 8: e58934. PMID 23536837 DOI: 10.1371/Journal.Pone.0058934 |
0.658 |
|
| 2013 |
Mast AE, Schlumpf KS, Wright DJ, Johnson B, Glynn SA, Busch MP, Olbina G, Westerman M, Nemeth E, Ganz T. Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy. Haematologica. 98: 1324-30. PMID 23445875 DOI: 10.3324/Haematol.2012.070979 |
0.689 |
|
| 2013 |
Guo W, Bachman E, Li M, Roy CN, Blusztajn J, Wong S, Chan SY, Serra C, Jasuja R, Travison TG, Muckenthaler MU, Nemeth E, Bhasin S. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell. 12: 280-91. PMID 23399021 DOI: 10.1111/Acel.12052 |
0.525 |
|
| 2013 |
Fung E, Sugianto P, Hsu J, Damoiseaux R, Ganz T, Nemeth E. High-throughput screening of small molecules identifies hepcidin antagonists. Molecular Pharmacology. 83: 681-90. PMID 23292796 DOI: 10.1124/Mol.112.083428 |
0.69 |
|
| 2013 |
Basseri RJ, Nemeth E, Vassilaki ME, Basseri B, Enayati P, Shaye O, Bourikas LA, Ganz T, Papadakis KA. Hepcidin is a key mediator of anemia of inflammation in Crohn's disease. Journal of Crohn's & Colitis. 7: e286-91. PMID 23219355 DOI: 10.1016/J.Crohns.2012.10.013 |
0.521 |
|
| 2013 |
Casu C, Goldberg A, Nemeth E, Ganz T, Gardenghi S, MacDonald B, Rivella S. Treatment With Minihepcidin Peptide Improves Anemia and Iron Overload In a Mouse Model Of Thalassemia Intermedia Blood. 122: 431-431. DOI: 10.1182/Blood.V122.21.431.431 |
0.743 |
|
| 2013 |
Kautz L, Jung G, Nemeth E, Ganz T. The Erythroid Factor Erythroferrone and Its Role In Iron Homeostasis Blood. 122: 4-4. DOI: 10.1182/Blood.V122.21.4.4 |
0.739 |
|
| 2013 |
Arezes J, Jung G, Gabayan V, Valore E, Ganz T, Bulut Y, Nemeth E. Hepcidin-Induced Hypoferremia Is a Host-Defense Mechanism Against Siderophilic Bacteria Blood. 122: 176-176. DOI: 10.1182/Blood.V122.21.176.176 |
0.718 |
|
| 2013 |
Condon F, Li H, Kessler D, Nandi V, Ganz T, Nemeth E, Westerman M, Shaz BH, Ginzburg Y. Evidence Of Relative Iron Deficiency in Apheresis Platelet Donors Correlates With Donation Frequency Blood. 122: 1155-1155. DOI: 10.1182/Blood.V122.21.1155.1155 |
0.632 |
|
| 2012 |
Ganz T, Goff J, Klasing K, Nemeth E, Roth T. IOD in rhinos--immunity group report: report from the Immunity, Genetics and Toxicology Working Group of the International Workshop on Iron Overload Disorder in Browsing Rhinoceros (February 2011). Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians. 43: S117-9. PMID 23156715 DOI: 10.1638/1042-7260-43.3S.S117 |
0.562 |
|
| 2012 |
Ganz T, Nemeth E. Iron homeostasis and its disorders in mice and men: potential lessons for rhinos. Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians. 43: S19-26. PMID 23156702 DOI: 10.1638/2011-0158.1 |
0.73 |
|
| 2012 |
Ramos E, Ruchala P, Goodnough JB, Kautz L, Preza GC, Nemeth E, Ganz T. Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood. 120: 3829-36. PMID 22990014 DOI: 10.1182/Blood-2012-07-440743 |
0.764 |
|
| 2012 |
Tussing-Humphreys L, Pusatcioglu C, Pustacioglu C, Nemeth E, Braunschweig C. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. Journal of the Academy of Nutrition and Dietetics. 112: 391-400. PMID 22717199 DOI: 10.1016/J.Jada.2011.08.038 |
0.682 |
|
| 2012 |
Qiao B, Sugianto P, Fung E, Del-Castillo-Rueda A, Moran-Jimenez MJ, Ganz T, Nemeth E. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metabolism. 15: 918-24. PMID 22682227 DOI: 10.1016/J.Cmet.2012.03.018 |
0.742 |
|
| 2012 |
Ross SL, Tran L, Winters A, Lee KJ, Plewa C, Foltz I, King C, Miranda LP, Allen J, Beckman H, Cooke KS, Moody G, Sasu BJ, Nemeth E, Ganz T, et al. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metabolism. 15: 905-17. PMID 22682226 DOI: 10.1016/J.Cmet.2012.03.017 |
0.581 |
|
| 2012 |
Ravasi G, Pelucchi S, Trombini P, Mariani R, Tomosugi N, Modignani GL, Pozzi M, Nemeth E, Ganz T, Hayashi H, Barisani D, Piperno A. Hepcidin expression in iron overload diseases is variably modulated by circulating factors. Plos One. 7: e36425. PMID 22586470 DOI: 10.1371/Journal.Pone.0036425 |
0.629 |
|
| 2012 |
Ganz T, Nemeth E. Iron metabolism: interactions with normal and disordered erythropoiesis. Cold Spring Harbor Perspectives in Medicine. 2: a011668. PMID 22553501 DOI: 10.1101/Cshperspect.A011668 |
0.722 |
|
| 2012 |
Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochimica Et Biophysica Acta. 1823: 1434-43. PMID 22306005 DOI: 10.1016/J.Bbamcr.2012.01.014 |
0.768 |
|
| 2012 |
Goodnough JB, Ramos E, Nemeth E, Ganz T. Inhibition of hepcidin transcription by growth factors. Hepatology (Baltimore, Md.). 56: 291-9. PMID 22278715 DOI: 10.1002/Hep.25615 |
0.544 |
|
| 2011 |
Ganz T, Nemeth E. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2011: 538-42. PMID 22160086 DOI: 10.1182/Asheducation-2011.1.538 |
0.728 |
|
| 2011 |
Tussing-Humphreys L, Frayn KN, Smith SR, Westerman M, Dennis AL, Nemeth E, Thomson J, Pusatcioglu C. Subcutaneous adipose tissue from obese and lean adults does not release hepcidin in vivo. Thescientificworldjournal. 11: 2197-206. PMID 22125467 DOI: 10.1100/2011/634861 |
0.374 |
|
| 2011 |
Preza GC, Ruchala P, Pinon R, Ramos E, Qiao B, Peralta MA, Sharma S, Waring A, Ganz T, Nemeth E. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. The Journal of Clinical Investigation. 121: 4880-8. PMID 22045566 DOI: 10.1172/Jci57693 |
0.746 |
|
| 2011 |
Trombini P, Paolini V, Pelucchi S, Mariani R, Nemeth E, Ganz T, Piperno A. Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome. Liver International : Official Journal of the International Association For the Study of the Liver. 31: 994-1000. PMID 21733088 DOI: 10.1111/J.1478-3231.2011.02520.X |
0.769 |
|
| 2011 |
Pasricha SR, McQuilten Z, Westerman M, Keller A, Nemeth E, Ganz T, Wood E. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica. 96: 1099-105. PMID 21508121 DOI: 10.3324/Haematol.2010.037960 |
0.741 |
|
| 2011 |
Ramos E, Kautz L, Rodriguez R, Hansen M, Gabayan V, Ginzburg Y, Roth MP, Nemeth E, Ganz T. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology (Baltimore, Md.). 53: 1333-41. PMID 21480335 DOI: 10.1002/Hep.24178 |
0.75 |
|
| 2011 |
Clark RJ, Tan CC, Preza GC, Nemeth E, Ganz T, Craik DJ. Understanding the structure/activity relationships of the iron regulatory peptide hepcidin. Chemistry & Biology. 18: 336-43. PMID 21439478 DOI: 10.1002/Psc.2448 |
0.715 |
|
| 2011 |
Girelli D, Trombini P, Busti F, Campostrini N, Sandri M, Pelucchi S, Westerman M, Ganz T, Nemeth E, Piperno A, Camaschella C. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica. 96: 500-6. PMID 21173098 DOI: 10.3324/Haematol.2010.033449 |
0.757 |
|
| 2011 |
Ganz T, Nemeth E. Hepcidin and disorders of iron metabolism. Annual Review of Medicine. 62: 347-60. PMID 20887198 DOI: 10.1146/Annurev-Med-050109-142444 |
0.753 |
|
| 2011 |
Burpee T, Mitchell P, Fishman D, Islam S, Nemeth E, Westerman M, Wessling-Resnick M, Grand RJ. Intestinal ferroportin expression in pediatric Crohn's disease. Inflammatory Bowel Diseases. 17: 524-31. PMID 20564534 DOI: 10.1002/Ibd.21367 |
0.379 |
|
| 2011 |
Nemeth E, Ramos E, Ruchala P, Preza G, Ganz T. Mini-Hepcidins Prevent Iron Overload In A Mouse Model of Hereditary Hemochromatosis Blood. 118: 689-689. DOI: 10.1182/Blood.V118.21.689.689 |
0.746 |
|
| 2011 |
Wang S, Li H, Sarran L, Olbina G, Westerman M, Nemeth E, Bouhassira EE, Ganz T, Ginzburg Y. Hepcidin in Male Double Red Blood Cell Donors - Relationship Between Parameters of Iron Metabolism and Erythropoiesis Blood. 118: 2109-2109. DOI: 10.1182/Blood.V118.21.2109.2109 |
0.696 |
|
| 2010 |
Kautz L, Nemeth E. Novel tools for the evaluation of iron metabolism. Haematologica. 95: 1989-91. PMID 21123438 DOI: 10.3324/Haematol.2010.033993 |
0.66 |
|
| 2010 |
Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, Guy E, Muirhead K, Rao N, Roy CN, Andrews NC, Nemeth E, Follenzi A, An X, Mohandas N, Ginzburg Y, et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. The Journal of Clinical Investigation. 120: 4466-77. PMID 21099112 DOI: 10.1172/Jci41717 |
0.681 |
|
| 2010 |
Nemeth E. Hepcidin biology and therapeutic applications. Expert Review of Hematology. 3: 153-5. PMID 21083458 DOI: 10.1586/Ehm.10.1 |
0.676 |
|
| 2010 |
Rivella S, Nemeth E, Miller JL. Crosstalk between Erythropoiesis and Iron Metabolism. Advances in Hematology. 2010. PMID 20862206 DOI: 10.1155/2010/317095 |
0.652 |
|
| 2010 |
Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 116: 4754-61. PMID 20826717 DOI: 10.1182/Blood-2010-05-286260 |
0.731 |
|
| 2010 |
Nemeth E. Hepcidin in beta-thalassemia. Annals of the New York Academy of Sciences. 1202: 31-5. PMID 20712769 DOI: 10.1111/J.1749-6632.2010.05585.X |
0.662 |
|
| 2010 |
Maes K, Nemeth E, Roodman GD, Huston A, Esteve F, Freytes C, Callander N, Katodritou E, Tussing-Humphreys L, Rivera S, Vanderkerken K, Lichtenstein A, Ganz T. In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood. 116: 3635-44. PMID 20679527 DOI: 10.1182/Blood-2010-03-274571 |
0.537 |
|
| 2010 |
Ayoya MA, Spiekermann-Brouwer GM, Stoltzfus RJ, Nemeth E, Habicht JP, Ganz T, Rawat R, Traoré AK, Garza C. Alpha 1-acid glycoprotein, hepcidin, C-reactive protein, and serum ferritin are correlated in anemic schoolchildren with Schistosoma haematobium. The American Journal of Clinical Nutrition. 91: 1784-90. PMID 20410090 DOI: 10.3945/Ajcn.2010.29353 |
0.605 |
|
| 2010 |
Zaritsky J, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, Nemeth E, Ganz T, Salusky IB. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1010-4. PMID 20299375 DOI: 10.2215/Cjn.08161109 |
0.636 |
|
| 2010 |
Ferrucci L, Semba RD, Guralnik JM, Ershler WB, Bandinelli S, Patel KV, Sun K, Woodman RC, Andrews NC, Cotter RJ, Ganz T, Nemeth E, Longo DL. Proinflammatory state, hepcidin, and anemia in older persons. Blood. 115: 3810-6. PMID 20081092 DOI: 10.1182/Blood-2009-02-201087 |
0.692 |
|
| 2010 |
Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Holterman AX, Galvani C, Ayloo S, Vitello J, Braunschweig C. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity (Silver Spring, Md.). 18: 2010-6. PMID 20075851 DOI: 10.1038/Oby.2009.490 |
0.611 |
|
| 2010 |
Nemeth E. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Advances in Hematology. 2010: 750643. PMID 20066043 DOI: 10.1155/2010/750643 |
0.68 |
|
| 2010 |
Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Guzman G, Holterman AX, Braunschweig C. Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity (Silver Spring, Md.). 18: 1449-56. PMID 19816411 DOI: 10.1038/Oby.2009.319 |
0.56 |
|
| 2010 |
Pasricha SS, McQuilten Z, Westerman M, Keller A, Nemeth E, Ganz T, Wood EM. Is Serum Hepcidin a Useful Diagnostic Test for Iron Deficiency? Blood. 116: 2056-2056. DOI: 10.1182/Blood.V116.21.2056.2056 |
0.725 |
|
| 2010 |
Pasricha SS, McQuilten Z, Westerman M, Keller A, Nemeth E, Ganz T, Wood EM. Iron Deficiency without Anemia In Premenopausal Blood Donors Is Associated with Future Deferral From Whole Blood Donation. Blood. 116: 1110-1110. DOI: 10.1182/Blood.V116.21.1110.1110 |
0.69 |
|
| 2010 |
Gardenghi S, Ramos P, Roy CN, Andrews NC, Nemeth E, An X, Narla M, Ginzburg Y, Rachmilewitz EA, Giardina P, Grady RW, Rivella S. Hepcidin as a Therapeutic Tool to Limit Iron Overload and Improve Anemia In β-Thalassemia Blood. 116: 1009-1009. DOI: 10.1182/Blood.V116.21.1009.1009 |
0.601 |
|
| 2010 |
Westerman ME, Olbina G, Ostland VE, Nemeth E, Ganz T. Hepcidin: An emerging biomarker for iron disorders, inflammatory diseases, and infections Proceedings of Spie - the International Society For Optical Engineering. 7666. DOI: 10.1117/12.854910 |
0.776 |
|
| 2010 |
Pozzi M, Pelucchi S, Trombini P, Mariani R, Coletti S, Vanessi S, Nemeth E, Tomosugi N, Barisani D, Piperno A. F.N.38 HEPCIDIN EXPRESSION AT HEPATIC, SERUM AND URINARY LEVEL IN SUBJECTS WITH DIFFERENT IRON PHENOTYPES Digestive and Liver Disease. 42: S47. DOI: 10.1016/S1590-8658(10)60492-6 |
0.385 |
|
| 2010 |
Trombini P, Busti F, Campostrini N, Sandri M, Pelucchi S, Nemeth E, Ganz T, Camaschella C, Girelli D, Piperno A. 1 TIME COURSE OF HEPCIDIN RESPONSE TO ORAL IRON TEST CLARIFIES THE ROLE OF HFE AND TFR2 IN IRON SENSING Digestive and Liver Disease. 42: S1. DOI: 10.1016/S1590-8658(10)00093-9 |
0.692 |
|
| 2010 |
Trombini P, Busti F, Campostrini N, Sandri M, Pelucchi S, Nemeth E, Ganz T, Camaschella C, Girelli D, Piperno A. 1133 A TIME COURSE OF HEPCIDIN RESPONSE TO ORAL IRON CHALLENGE IN HFE AND TFR2 HEMOCHROMATOSIS PATIENTS Journal of Hepatology. 52: S437. DOI: 10.1016/S0168-8278(10)61134-8 |
0.726 |
|
| 2009 |
Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematologica. 122: 78-86. PMID 19907144 DOI: 10.1159/000243791 |
0.759 |
|
| 2009 |
Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Seminars in Hematology. 46: 387-93. PMID 19786207 DOI: 10.1053/J.Seminhematol.2009.06.001 |
0.758 |
|
| 2009 |
Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, Castagna A, Busti F, Campostrini N, Martinelli N, Vantini I, Corrocher R, Ganz T, Fattovich G. Reduced serum hepcidin levels in patients with chronic hepatitis C. Journal of Hepatology. 51: 845-52. PMID 19729219 DOI: 10.1016/J.Jhep.2009.06.027 |
0.716 |
|
| 2009 |
Sham RL, Phatak PD, Nemeth E, Ganz T. Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood. 114: 493-4. PMID 19589941 DOI: 10.1182/Blood-2009-04-216226 |
0.721 |
|
| 2009 |
Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 4: 1051-6. PMID 19406957 DOI: 10.2215/Cjn.05931108 |
0.676 |
|
| 2009 |
Ruivard M, Lainé F, Ganz T, Olbina G, Westerman M, Nemeth E, Rambeau M, Mazur A, Gerbaud L, Tournilhac V, Abergel A, Philippe P, Deugnier Y, Coudray C. Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. Journal of Hepatology. 50: 1219-25. PMID 19398238 DOI: 10.1016/J.Jhep.2009.01.029 |
0.719 |
|
| 2009 |
Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, Nemeth E. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood. 114: 437-43. PMID 19383972 DOI: 10.1182/Blood-2008-03-146134 |
0.689 |
|
| 2009 |
Troadec MB, Lainé F, Daniel V, Rochcongar P, Ropert M, Cabillic F, Perrin M, Morcet J, Loréal O, Olbina G, Westerman M, Nemeth E, Ganz T, Brissot P. Daily regulation of serum and urinary hepcidin is not influenced by submaximal cycling exercise in humans with normal iron metabolism. European Journal of Applied Physiology. 106: 435-43. PMID 19306018 DOI: 10.1007/S00421-009-1031-8 |
0.641 |
|
| 2009 |
Tussing-Humphreys LM, Liang H, Nemeth E, Freels S, Braunschweig CA. Excess adiposity, inflammation, and iron-deficiency in female adolescents. Journal of the American Dietetic Association. 109: 297-302. PMID 19167957 DOI: 10.1016/J.Jada.2008.10.044 |
0.577 |
|
| 2009 |
Nemeth E. Development of Hepcidin Agonists and Antagonists. Blood. 114: SCI-27-SCI-27. DOI: 10.1182/Blood.V114.22.Sci-27.Sci-27 |
0.657 |
|
| 2009 |
Maes K, Huston A, Roodman D, Rivera S, Nemeth E, Lichtenstein A, Vanderkerken K, Ganz T. Characterization of Hepcidin-Inducing Cytokines in Multiple Myeloma. Blood. 114: 2001-2001. DOI: 10.1182/Blood.V114.22.2001.2001 |
0.539 |
|
| 2009 |
Bourikas L, Enayati P, Shaye O, Nemeth E, Ganz T, Papadakis K. P028 - The role of hepcidin in Crohn's disease associated anemia Journal of Crohn's and Colitis. 3: S22. DOI: 10.1016/S1873-9946(09)60055-6 |
0.399 |
|
| 2009 |
Paolini V, Trombini P, Pelucchi S, Mariani R, Salvioni A, Pozzi M, Nemeth E, Ganz T, Piperno A. 1015 DYSMETABOLIC HEPATIC IRON OVERLOAD SYNDROME: ANALYSIS OF HEPCIDIN RESPONSE TO ACUTE ORAL IRON AND CHRONIC IRON OVERLOAD Journal of Hepatology. 50: S367-S368. DOI: 10.1016/S0168-8278(09)61017-5 |
0.699 |
|
| 2009 |
Bourikas LA, Enayati P, Shaye O, Nemeth E, Ganz T, Papadakis KA. S1109 The Role of Hepcidin in Crohn's Disease (CD)-Associated Anemia Gastroenterology. 136: A-190-A-191. DOI: 10.1016/S0016-5085(09)60858-1 |
0.443 |
|
| 2008 |
Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 112: 4292-7. PMID 18689548 DOI: 10.1182/Blood-2008-02-139915 |
0.609 |
|
| 2008 |
De Domenico I, Nemeth E, Nelson JM, Phillips JD, Ajioka RS, Kay MS, Kushner JP, Ganz T, Ward DM, Kaplan J. The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metabolism. 8: 146-56. PMID 18680715 DOI: 10.1016/J.Cmet.2008.07.002 |
0.606 |
|
| 2008 |
Sharma S, Nemeth E, Chen YH, Goodnough J, Huston A, Roodman GD, Ganz T, Lichtenstein A. Involvement of hepcidin in the anemia of multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3262-7. PMID 18519751 DOI: 10.1158/1078-0432.Ccr-07-4153 |
0.503 |
|
| 2008 |
Winder A, Lefkowitz R, Ghoti H, Leiba M, Ganz T, Nemeth E, Rachmilewitz EA. Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis. British Journal of Haematology. 142: 669-71. PMID 18498424 DOI: 10.1111/J.1365-2141.2008.07225.X |
0.438 |
|
| 2008 |
Barisani D, Pelucchi S, Mariani R, Galimberti S, Trombini P, Fumagalli D, Meneveri R, Nemeth E, Ganz T, Piperno A. Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload. Journal of Hepatology. 49: 123-33. PMID 18462824 DOI: 10.1016/J.Jhep.2008.03.011 |
0.748 |
|
| 2008 |
Nemeth E. Iron regulation and erythropoiesis. Current Opinion in Hematology. 15: 169-75. PMID 18391780 DOI: 10.1097/Moh.0B013E3282F73335 |
0.648 |
|
| 2008 |
Bozzini C, Campostrini N, Trombini P, Nemeth E, Castagna A, Tenuti I, Corrocher R, Camaschella C, Ganz T, Olivieri O, Piperno A, Girelli D. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells, Molecules & Diseases. 40: 347-52. PMID 18164223 DOI: 10.1182/Blood.V110.11.2668.2668 |
0.542 |
|
| 2008 |
Lin L, Nemeth E, Goodnough JB, Thapa DR, Gabayan V, Ganz T. Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells, Molecules & Diseases. 40: 122-31. PMID 17869549 DOI: 10.1016/J.Bcmd.2007.06.023 |
0.709 |
|
| 2008 |
Olbina G, Pastorino X, Girelli D, O’Brien KO, Nemeth E, Ganz T, Westerman M. Immunoassay for Human Hepcidin in Blood Blood. 112: 3839-3839. DOI: 10.1182/Blood.V112.11.3839.3839 |
0.663 |
|
| 2008 |
Girelli D, Pasino M, Goodnough J, Nemeth E, Castagna A, Busti F, Campostrini N, Martinelli N, Guido M, Vantini I, Corrocher R, Ganz T, Fattovich G. Hepcidin Suppression Relative to Iron Status in Patients with Chronic Hepatitis C. Blood. 112: 1860-1860. DOI: 10.1182/Blood.V112.11.1860.1860 |
0.693 |
|
| 2008 |
Gardenghi S, Marongiu MF, Muirhead K, Ramos P, Roy CN, Andrews NC, Nemeth E, Follenzi A, Rachmilewitz E, Giardina P, Grady RW, Rivella S. Increased Hepcidin Expression in Mice Affected by β-Thalassemia Reduces Iron Overload with No Effect on Anemia Blood. 112: 128-128. DOI: 10.1182/BLOOD.V112.11.128.128 |
0.536 |
|
| 2008 |
Preza G, Fernandes A, Clark RJ, Craik DJ, Ganz T, Nemeth E. Structural Aspects of Hepcidin-Ferroportin Binding Blood. 112: 119-119. DOI: 10.1182/Blood.V112.11.119.119 |
0.652 |
|
| 2007 |
Trombini P, Coliva T, Nemeth E, Mariani R, Ganz T, Biondi A, Piperno A. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica. 92: 1407-10. PMID 17768112 DOI: 10.3324/Haematol.11377 |
0.729 |
|
| 2007 |
Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E, Phung Y, Ganz T, Camaschella C. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood. 110: 4096-100. PMID 17724144 DOI: 10.1182/Blood-2007-06-096503 |
0.753 |
|
| 2007 |
Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood. 110: 2182-9. PMID 17540841 DOI: 10.1182/Blood-2007-04-087593 |
0.746 |
|
| 2007 |
Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica. 92: 583-8. PMID 17488680 DOI: 10.3324/Haematol.10842 |
0.766 |
|
| 2007 |
De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, Ganz T, Musci G, Kaplan J. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Molecular Biology of the Cell. 18: 2569-78. PMID 17475779 DOI: 10.1091/Mbc.E07-01-0060 |
0.6 |
|
| 2007 |
Kearney SL, Nemeth E, Neufeld EJ, Thapa D, Ganz T, Weinstein DA, Cunningham MJ. Urinary hepcidin in congenital chronic anemias. Pediatric Blood & Cancer. 48: 57-63. PMID 16220548 DOI: 10.1002/Pbc.20616 |
0.731 |
|
| 2007 |
Nemeth E, Ganz T. Iron and aging Blood Disorders in the Elderly. 171-180. DOI: 10.1017/CBO9780511545238.014 |
0.654 |
|
| 2007 |
Winder A, Lefkowitz R, Ghoti H, Leiba M, Ganz T, Nemeth E, Rachmilewitz E. P034 Urinary hepcidin excretion in patients with myelodysplastic syndrome (MDS) and myelofibrosis (MF) Leukemia Research. 31: S59-S60. DOI: 10.1016/S0145-2126(07)70104-2 |
0.368 |
|
| 2006 |
Semrin G, Fishman DS, Bousvaros A, Zholudev A, Saunders AC, Correia CE, Nemeth E, Grand RJ, Weinstein DA. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflammatory Bowel Diseases. 12: 1101-6. PMID 17119383 DOI: 10.1097/01.Mib.0000235097.86360.04 |
0.592 |
|
| 2006 |
De Domenico I, McVey Ward D, Nemeth E, Ganz T, Corradini E, Ferrara F, Musci G, Pietrangelo A, Kaplan J. Molecular and clinical correlates in iron overload associated with mutations in ferroportin. Haematologica. 91: 1092-5. PMID 16885049 |
0.638 |
|
| 2006 |
Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annual Review of Nutrition. 26: 323-42. PMID 16848710 DOI: 10.1146/Annurev.Nutr.26.061505.111303 |
0.774 |
|
| 2006 |
Pospisilova D, Mims MP, Nemeth E, Ganz T, Prchal JT. DMT1 mutation: response of anemia to darbepoetin administration and implications for iron homeostasis. Blood. 108: 404-5. PMID 16790587 DOI: 10.1182/Blood-2006-02-003962 |
0.733 |
|
| 2006 |
Ganz T, Nemeth E. Regulation of iron acquisition and iron distribution in mammals. Biochimica Et Biophysica Acta. 1763: 690-9. PMID 16790283 DOI: 10.1016/J.Bbamcr.2006.03.014 |
0.77 |
|
| 2006 |
Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica. 91: 727-32. PMID 16769573 |
0.663 |
|
| 2006 |
Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. American Journal of Physiology. Gastrointestinal and Liver Physiology. 290: G199-203. PMID 16407589 DOI: 10.1152/Ajpgi.00412.2005 |
0.765 |
|
| 2006 |
Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood. 107: 328-33. PMID 16141345 DOI: 10.1182/Blood-2005-05-2049 |
0.574 |
|
| 2006 |
Sharma S, Nemeth E, Chen Y, Huston A, Roodman G, Goodnough J, Ganz T, Lichtenstein A. Hepcidin Overproduction Mediates the Anemia of Multiple Myeloma. Blood. 108: 516-516. DOI: 10.1182/Blood.V108.11.516.516 |
0.556 |
|
| 2006 |
Winder A, Lefkowitz R, Ghoti H, Leiba M, Ganz T, Nemeth E, Rachmilewitz E. Urinary Hepcidin Excretion in Patients with Myelodysplastic Syndrome (MDS) and Myelofibrosis (MF). Blood. 108: 2620-2620. DOI: 10.1182/Blood.V108.11.2620.2620 |
0.664 |
|
| 2005 |
Roecker L, Meier-Buttermilch R, Brechtel L, Nemeth E, Ganz T. Iron-regulatory protein hepcidin is increased in female athletes after a marathon. European Journal of Applied Physiology. 95: 569-71. PMID 16249921 DOI: 10.1007/S00421-005-0055-Y |
0.593 |
|
| 2005 |
Porto G, Roetto A, Daraio F, Pinto JP, Almeida S, Bacelar C, Nemeth E, Ganz T, Camaschella C. A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron. Blood. 106: 2922-3. PMID 16204153 DOI: 10.1182/Blood-2005-04-1630 |
0.481 |
|
| 2005 |
Kemna E, Tjalsma H, Laarakkers C, Nemeth E, Willems H, Swinkels D. Novel urine hepcidin assay by mass spectrometry. Blood. 106: 3268-70. PMID 16030189 DOI: 10.1182/Blood-2005-05-1873 |
0.417 |
|
| 2005 |
Zoller H, McFarlane I, Theurl I, Stadlmann S, Nemeth E, Oxley D, Ganz T, Halsall DJ, Cox TM, Vogel W. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology (Baltimore, Md.). 42: 466-72. PMID 15986403 DOI: 10.1002/Hep.20775 |
0.727 |
|
| 2005 |
De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, Kaplan J. The molecular basis of ferroportin-linked hemochromatosis. Proceedings of the National Academy of Sciences of the United States of America. 102: 8955-60. PMID 15956209 DOI: 10.1073/Pnas.0503804102 |
0.641 |
|
| 2005 |
Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 106: 2196-9. PMID 15933050 DOI: 10.1182/Blood-2005-04-1766 |
0.745 |
|
| 2005 |
Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 106: 1864-6. PMID 15886319 DOI: 10.1182/Blood-2005-03-1159 |
0.568 |
|
| 2005 |
Détivaud L, Nemeth E, Boudjema K, Turlin B, Troadec MB, Leroyer P, Ropert M, Jacquelinet S, Courselaud B, Ganz T, Brissot P, Loréal O. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood. 106: 746-8. PMID 15797999 DOI: 10.1182/Blood-2004-12-4855 |
0.66 |
|
| 2005 |
Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T, Nemeth E. Hepcidin in iron overload disorders. Blood. 105: 4103-5. PMID 15671438 DOI: 10.1182/Blood-2004-12-4844 |
0.763 |
|
| 2005 |
Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood. 105: 1803-6. PMID 15486069 DOI: 10.1182/Blood-2004-08-3042 |
0.696 |
|
| 2005 |
Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood. 105: 1797-802. PMID 15479721 DOI: 10.1182/Blood-2004-08-3375 |
0.703 |
|
| 2005 |
Nemeth E, Loreal O, Le Lan C, Ropert M, Troadec M, Detivaud L, Jard C, Pouchard M, Le Treut A, Deugnier Y, Ganz T, Brissot P. Altered Hepcidin Regulation in Hereditary Hemochromatosis and Dysmetabolic Hyperferritinemia. Blood. 106: 3590-3590. DOI: 10.1182/Blood.V106.11.3590.3590 |
0.743 |
|
| 2005 |
Nemeth E, Origa R, Ganz T, Galanello R. Urinary Hepcidin in Thalassemic Syndromes. Blood. 106: 3589-3589. DOI: 10.1182/Blood.V106.11.3589.3589 |
0.756 |
|
| 2005 |
Nemeth E. Ferroportin mutations: a tale of two phenotypes Blood. 105: 3763-3764. DOI: 10.1182/Blood-2005-02-0771 |
0.439 |
|
| 2004 |
Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (New York, N.Y.). 306: 2090-3. PMID 15514116 DOI: 10.1126/Science.1104742 |
0.746 |
|
| 2004 |
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. The Journal of Clinical Investigation. 113: 1271-6. PMID 15124018 DOI: 10.1172/Jci20945 |
0.601 |
|
| 2004 |
Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dubé MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nature Genetics. 36: 77-82. PMID 14647275 DOI: 10.1038/Ng1274 |
0.63 |
|
| 2004 |
Rivera S, Liu L, Nemeth E, Gabayan V, Ganz T. Hepcidin Contributes to Anemia of Malignancy by Causing Sequestration of Iron in Hepatic Stores. Blood. 104: 3197-3197. DOI: 10.1182/Blood.V104.11.3197.3197 |
0.718 |
|
| 2004 |
Nemeth E, Keller C, Taudorf S, Pedersen BK, Ganz T. 5 REGULATION OF HEPCIDIN RELEASE BY IL-6 AND DIETARY IRON IN HUMAN VOLUNTEERS. Journal of Investigative Medicine. 52: S401.5-S401. DOI: 10.1136/Jim-52-Suppl2-171 |
0.629 |
|
| 2004 |
Lin L, Nemeth E, Rivera S, Gabayan V, Ganz T. 4 IN VITRO ANALYSIS OF IRON-REGULATED HEPCIDIN EXPRESSION. Journal of Investigative Medicine. 52: S401.4-S401. DOI: 10.1136/Jim-52-Suppl2-170 |
0.72 |
|
| 2003 |
Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 101: 2461-3. PMID 12433676 DOI: 10.1182/Blood-2002-10-3235 |
0.712 |
|
| Show low-probability matches. |